Insulin Resistant

As per available reports about 100 journals, 162 Conferences, 30 workshops are presently dedicated exclusively to Insulin Resistant and about 366282 articles are being published on the current trends in Insulin Resistant. In terms of research annually, USA, India, Japan, Brazil and Canada are some of the leading countries where maximum studies related to proteomics are being carried out. As reported in article-  Anthony H. Cincotta-” Weighted Effects of Bromocriptine Treatment on Glucose Homeostasis during Hyperglycemic versus Euglycemic Clamp Conditions in Insulin Resistant Hamsters: Bromocriptine as a Unique Postprandial Insulin Sensitizer” article, Insulin resistant states that act in response to an acute hyperglycemic event such as feeding differ from and are more potent than those acting during fasting euglycemia, and this difference cannot be explained by or is not the result of a change (increase) in insulin during the meal or acute hyperglycemia. How might this unique phenomenon of an increased glucose control effect of bromocriptine during hyperglycemia versus euglycemia (relative to vehicle treated animals) at identical circulating insulin levels occur?

The Journal of Diabetes & Metabolism is an academic journal – hosted by OMICS International – a pioneer in open access publishing–and is listed among the top 10 in https://www.omicsonline.org/diabetes-metabolism.phpomicsonline.org/diabetes-metabolism.php. Each year research scientists have noticed a rise in the number of congresses being held in this field. The Journal of Diabetes & Metabolism provides a unique platform to researchers and scientist to explore the advanced and latest research developments in the field of Journal of Diabetes & Metabolism, thus bridging the gap between researchers and young scientists.